{"data":[{"accessionNo":"0000080255-26-000609","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"BETA BIONICS INC","ticker":"BBNX","cusip":"08659B102","securityClass":"COMMON STOCK","eventDate":"2026-09-30","reportingPerson":"T. Rowe Price Associates, Inc.","reportingCik":null,"personType":"IA","sharesOwned":8943061,"percentOfClass":16.6,"filedAt":"2026-10-07","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dapice Joshua J.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dreyfuss, Philip D.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Dunn Hannah E.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Gehani, Varun N.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Giauque, Nicolas","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Husen, Avner A.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Kim, David T.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Linn, Michael G.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Luo Patrick (Cheng)","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Roberts, Jr., Thomas G.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Saito Edric C.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Wehrly, Mark C.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Warren, John R.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Short Daniel S.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Spokes, Andrew J. M.","reportingCik":null,"personType":"HC,IN","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Management, L.L.C.","reportingCik":null,"personType":"IA,OO","sharesOwned":595000,"percentOfClass":1.3,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital F5 Master I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Zone Healthcare Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Institutional Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Four Crossings Institutional Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital Offshore Investors II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Capital (AM) Investors, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Partners, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon Institutional (GP) V, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000395","formType":"SCHEDULE 13G/A","amendmentNo":5,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-06-30","reportingPerson":"Farallon F5 (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-08-13","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000919574-26-004585","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-07-17","reportingPerson":"Divisadero Street Capital, LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":3072985,"percentOfClass":6.9,"filedAt":"2026-07-24","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000919574-26-004585","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-07-17","reportingPerson":"Divisadero Street Capital Management, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":3072985,"percentOfClass":6.9,"filedAt":"2026-07-24","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000919574-26-004585","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-07-17","reportingPerson":"William Zolezzi","reportingCik":null,"personType":"HC,IN","sharesOwned":3072985,"percentOfClass":6.9,"filedAt":"2026-07-24","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000919574-26-004585","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-07-17","reportingPerson":"Divisadero Street Partners GP, LLC","reportingCik":null,"personType":"HC,OO","sharesOwned":2612985,"percentOfClass":5.9,"filedAt":"2026-07-24","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000919574-26-004585","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-07-17","reportingPerson":"Divisadero Street Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2612985,"percentOfClass":5.9,"filedAt":"2026-07-24","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001580642-26-003198","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Finny Kuruvilla, M.D., Ph. D.","reportingCik":null,"personType":"HC,IN","sharesOwned":5945488,"percentOfClass":13.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001580642-26-003198","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Eventide Asset Management, LLC","reportingCik":null,"personType":"IA","sharesOwned":5945488,"percentOfClass":13.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001580642-26-003198","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share","eventDate":"2026-03-31","reportingPerson":"Robin C. John","reportingCik":null,"personType":"HC,IN","sharesOwned":5945488,"percentOfClass":13.4,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001493215-26-000092","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"BETA BIONICS, INC.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":2000000,"percentOfClass":4.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001493215-26-000092","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"BETA BIONICS, INC.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value","eventDate":"2026-03-31","reportingPerson":"RTW Investments, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2000000,"percentOfClass":4.5,"filedAt":"2026-05-15","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Husen, Avner A.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Giauque, Nicolas","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Gehani, Varun N.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Dunn Hannah E.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Dreyfuss, Philip D.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Dapice Joshua J.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Wehrly, Mark C.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Warren, John R.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Spokes, Andrew J. M.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Short Daniel S.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Saito Edric C.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Roberts, Jr., Thomas G.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Luo Patrick (Cheng)","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Linn, Michael G.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Kim, David T.","reportingCik":null,"personType":"IN","sharesOwned":3607920,"percentOfClass":8.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Zone Healthcare Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":2560220,"percentOfClass":5.8,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon Capital Management, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":2560220,"percentOfClass":5.8,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon Partners, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":1007460,"percentOfClass":2.3,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon Capital Offshore Investors II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":436671,"percentOfClass":1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon Capital Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":188360,"percentOfClass":0.4,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon Capital Institutional Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":197381,"percentOfClass":0.4,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon Institutional (GP) V, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":44541,"percentOfClass":0.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon Capital Institutional Partners II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":63438,"percentOfClass":0.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon Capital Institutional Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":48629,"percentOfClass":0.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Four Crossings Institutional Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":44541,"percentOfClass":0.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon Capital (AM) Investors, L.P.","reportingCik":null,"personType":"PN","sharesOwned":28440,"percentOfClass":0.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon Capital F5 Master I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":40240,"percentOfClass":0.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000226","formType":"SCHEDULE 13G/A","amendmentNo":4,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2026-03-31","reportingPerson":"Farallon F5 (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":40240,"percentOfClass":0.1,"filedAt":"2026-05-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-053982","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Levy Guy","reportingCik":null,"personType":"IN","sharesOwned":4354501,"percentOfClass":9.8,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-053982","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Soleus GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":4323714,"percentOfClass":9.7,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-053982","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Soleus Capital Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":4323714,"percentOfClass":9.7,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-053982","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Soleus Capital Master Fund, L.P.","reportingCik":null,"personType":"FI","sharesOwned":2619753,"percentOfClass":5.9,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-053982","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Soleus Capital Group, LLC","reportingCik":null,"personType":"OO","sharesOwned":2619753,"percentOfClass":5.9,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-053982","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Soleus Capital, LLC","reportingCik":null,"personType":"OO","sharesOwned":2619753,"percentOfClass":5.9,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-053982","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Soleus Private Equity GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":1703961,"percentOfClass":3.8,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-053982","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Soleus Private Equity Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1703961,"percentOfClass":3.8,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-053982","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock","eventDate":"2026-03-31","reportingPerson":"Soleus PE GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":1703961,"percentOfClass":3.8,"filedAt":"2026-05-08","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000102909-26-000724","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics Inc","ticker":"BBNX","cusip":"08659B102","securityClass":"Common Stock","eventDate":"2026-03-13","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-03-26","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000902664-26-001244","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Steven A. Cohen","reportingCik":null,"personType":"IN","sharesOwned":2290023,"percentOfClass":5.2,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000902664-26-001244","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Point72 Asset Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2290023,"percentOfClass":5.2,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000902664-26-001244","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2026-02-18","reportingPerson":"Point72 Capital Advisors, Inc.","reportingCik":null,"personType":"CO","sharesOwned":2290023,"percentOfClass":5.2,"filedAt":"2026-02-23","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001493215-26-000030","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"BETA BIONICS, INC.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"RTW Investments, LP","reportingCik":null,"personType":"IA,PN","sharesOwned":2500000,"percentOfClass":5.7,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001493215-26-000030","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"BETA BIONICS, INC.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value","eventDate":"2025-12-31","reportingPerson":"Roderick Wong","reportingCik":null,"personType":"HC,IN","sharesOwned":2500000,"percentOfClass":5.7,"filedAt":"2026-02-17","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Guy Levy","reportingCik":null,"personType":"IN","sharesOwned":2534565,"percentOfClass":5.8,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus Capital Management, L.P.","reportingCik":null,"personType":"PN","sharesOwned":2503778,"percentOfClass":5.7,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus GP, LLC","reportingCik":null,"personType":"OO","sharesOwned":2503778,"percentOfClass":5.7,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus Private Equity GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":1703961,"percentOfClass":3.9,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus Private Equity Fund II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":1703961,"percentOfClass":3.9,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus PE GP II, LLC","reportingCik":null,"personType":"OO","sharesOwned":1703961,"percentOfClass":3.9,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus Capital Master Fund, L.P.","reportingCik":null,"personType":"FI","sharesOwned":799817,"percentOfClass":1.8,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus Capital Group, LLC","reportingCik":null,"personType":"OO","sharesOwned":799817,"percentOfClass":1.8,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus Capital, LLC","reportingCik":null,"personType":"OO","sharesOwned":799817,"percentOfClass":1.8,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus Private Equity GP I, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus BB SPV, LLC","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus Private Equity Fund I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001213900-26-015648","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Soleus PE GP I, LLC","reportingCik":null,"personType":"OO","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000902219-26-000098","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Management Group LLP","reportingCik":null,"personType":"HC","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000902219-26-000098","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Group Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000902219-26-000098","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Investment Advisors Holdings LLP","reportingCik":null,"personType":"HC","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0002053997-26-000001","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-12-31","reportingPerson":"Wellington Hadley Harbor Aggregator IV, L.P.","reportingCik":null,"personType":"PN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-10","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Gehani, Varun N.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Short Daniel S.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Spokes, Andrew J. M.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Warren, John R.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Wehrly, Mark C.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Linn, Michael G.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Giauque, Nicolas","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Roberts, Jr., Thomas G.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Saito Edric C.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Husen, Avner A.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Kim, David T.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Luo Patrick (Cheng)","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dunn Hannah E.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dreyfuss, Philip D.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Dapice Joshua J.","reportingCik":null,"personType":"IN","sharesOwned":4379920,"percentOfClass":9.9,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Management, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":3277220,"percentOfClass":7.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Zone Healthcare Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":3277220,"percentOfClass":7.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Partners, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":1060139,"percentOfClass":2.4,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Offshore Investors II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":446621,"percentOfClass":1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":198706,"percentOfClass":0.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":212605,"percentOfClass":0.5,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":73147,"percentOfClass":0.2,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital (AM) Investors, L.P.","reportingCik":null,"personType":"PN","sharesOwned":29738,"percentOfClass":0.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Four Crossings Institutional Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":49357,"percentOfClass":0.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital Institutional Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":49965,"percentOfClass":0.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Institutional (GP) V, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":49357,"percentOfClass":0.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon F5 (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":42561,"percentOfClass":0.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Farallon Capital F5 Master I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":42561,"percentOfClass":0.1,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Patel, Rajiv A.","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Fried, Richard B","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-26-000062","formType":"SCHEDULE 13G/A","amendmentNo":3,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-12-31","reportingPerson":"Seybold, William","reportingCik":null,"personType":"IN","sharesOwned":0,"percentOfClass":0,"filedAt":"2026-02-09","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Luo Patrick (Cheng)","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Dreyfuss, Philip D.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Linn, Michael G.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Kim, David T.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Dapice Joshua J.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Giauque, Nicolas","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Saito Edric C.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Wehrly, Mark C.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Warren, John R.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Spokes, Andrew J. M.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Short Daniel S.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Seybold, William","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Gehani, Varun N.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Fried, Richard B","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Dunn Hannah E.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Roberts, Jr., Thomas G.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Patel, Rajiv A.","reportingCik":null,"personType":"IN","sharesOwned":4313920,"percentOfClass":9.9,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon Capital Management, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":3277220,"percentOfClass":7.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Zone Healthcare Holdings, LLC","reportingCik":null,"personType":"OO","sharesOwned":3277220,"percentOfClass":7.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon Partners, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":998059,"percentOfClass":2.3,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon Capital Offshore Investors II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":418307,"percentOfClass":1,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon Capital Institutional Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":199940,"percentOfClass":0.5,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon Capital Partners, L.P.","reportingCik":null,"personType":"PN","sharesOwned":185460,"percentOfClass":0.4,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon Capital Institutional Partners II, L.P.","reportingCik":null,"personType":"PN","sharesOwned":70718,"percentOfClass":0.2,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon F5 (GP), L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":38641,"percentOfClass":0.1,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon Capital F5 Master I, L.P.","reportingCik":null,"personType":"PN","sharesOwned":38641,"percentOfClass":0.1,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon Capital (AM) Investors, L.P.","reportingCik":null,"personType":"PN","sharesOwned":28860,"percentOfClass":0.1,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Four Crossings Institutional Partners V, L.P.","reportingCik":null,"personType":"PN","sharesOwned":46974,"percentOfClass":0.1,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon Capital Institutional Partners III, L.P.","reportingCik":null,"personType":"PN","sharesOwned":47800,"percentOfClass":0.1,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000908834-25-000330","formType":"SCHEDULE 13G/A","amendmentNo":2,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, $0.0001 par value per share (the \"Shares\")","eventDate":"2025-09-30","reportingPerson":"Farallon Institutional (GP) V, L.L.C.","reportingCik":null,"personType":"OO","sharesOwned":46974,"percentOfClass":0.1,"filedAt":"2025-11-12","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000895421-25-000558","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Morgan Stanley","reportingCik":null,"personType":"HC,CO","sharesOwned":3739567,"percentOfClass":8.6,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000895421-25-000558","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"Morgan Stanley Capital Services LLC","reportingCik":null,"personType":"BD,CO","sharesOwned":3384256,"percentOfClass":7.8,"filedAt":"2025-11-07","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0000102909-25-000056","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics Inc","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"The Vanguard Group","reportingCik":null,"personType":"IA","sharesOwned":2216185,"percentOfClass":5.09,"filedAt":"2025-10-30","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0002012383-25-002510","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"BETA BIONICS INC","ticker":"BBNX","cusip":null,"securityClass":"Common Stock","eventDate":"2025-09-30","reportingPerson":"BlackRock, Inc.","reportingCik":null,"personType":"HC","sharesOwned":2778764,"percentOfClass":6.4,"filedAt":"2025-10-17","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001104659-25-100075","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":796964,"percentOfClass":1.8,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001104659-25-100075","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":796964,"percentOfClass":1.8,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001104659-25-100075","formType":"SCHEDULE 13G/A","amendmentNo":1,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-30","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":796964,"percentOfClass":1.8,"filedAt":"2025-10-16","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001104659-25-091669","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-15","reportingPerson":"Millennium Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2286728,"percentOfClass":5.3,"filedAt":"2025-09-19","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001104659-25-091669","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-15","reportingPerson":"Millennium Group Management LLC","reportingCik":null,"personType":"OO","sharesOwned":2286728,"percentOfClass":5.3,"filedAt":"2025-09-19","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"},{"accessionNo":"0001104659-25-091669","formType":"SCHEDULE 13G","amendmentNo":null,"issuerCik":"0001674632","issuerName":"Beta Bionics, Inc.","ticker":"BBNX","cusip":null,"securityClass":"Common Stock, par value $0.0001 per share","eventDate":"2025-09-15","reportingPerson":"Israel A. Englander","reportingCik":null,"personType":"IN","sharesOwned":2286728,"percentOfClass":5.3,"filedAt":"2025-09-19","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx"}],"updatedAt":"2026-10-25T03:09:31.130Z","source":"xoomar.com","docs":"https://xoomar.com/markets/api","license":"https://xoomar.com/terms","attribution":"Credit XOOMAR with a link to the dataset page on xoomar.com when you republish this data","canonicalUrl":"https://xoomar.com/markets/stocks/bbnx","meta":{"source":"SEC","sourceAttribution":"Schedule 13D and 13G data: SEC.","notice":"10 requests a minute without a key, 30 with a free key. Get a free key at https://xoomar.com/signup?utm_source=api, register your app at https://xoomar.com/developers/register?utm_source=api, and credit the data as \"Data: XOOMAR\" together with the sourceAttribution line."}}